The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. Retatrutide, Eli Lilly and Company, Obesity, Knees, Arthritis, Clinical Trials, GLP-1 RAs (Drug), Research Read More
New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial
